Investment
Features
FeesSafety
Academy
More
Pluang+

Immunovant shares drop 6% after lupus drug study fails primary goal, triggering investor lawsuit probe

Market News
25 Sep 2026
PRNewsWire
View Source
Bearish
Immunovant shares drop 6% after lupus drug study fails primary goal, triggering investor lawsuit probe

Immunovant's stock fell about 6% to a three-month low after its IMVT-1402 cutaneous lupus study missed the primary endpoint, leading the company to discontinue the lupus program. This setback caused a sharp decline in share price, prompting a securities law investigation by Levi & Korsinsky LLP on behalf of investors who suffered losses. Investors who bought shares at inflated prices may be eligible to recover losses through legal action. The investigation focuses on whether Immunovant made misleading statements about the drug's clinical prospects.

Immunovant's recent clinical trial setback and investigation notice provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 25, 2026 23:42 WIB: out of 100 priced health-sector US stocks, 52 rose and 48 fell. Notable movers include INO at USD 1.18 with a 1-day change of -2.48% and 100% buy order activity, DVA at USD 178.91 up 2.43% with 100% buy orders, and CTXR at USD 0.58 up 2.39%, with typical hold times ranging from 16 to 112 days.

More News

Ivanhoe Electric's copper project shows strong economics, with a 54% upside price target from Scotiabank.

Ivanhoe Electric's copper project shows strong economics, with a 54% upside price target from Scotiabank.

Ivanhoe Electric's Santa Cruz Copper Mining Project in Arizona has strong economic potential, according to a recent Preliminary Feasibility Study. The project requires $1.43 billion in initial capital and expects low operating costs of $1.47 per poun...

Analyst Insights
Bullish
2 hours ago
Westlake stock shows 46% upside with rising institutional stakes and expanded distribution deals.

Westlake stock shows 46% upside with rising institutional stakes and expanded distribution deals.

Westlake, a global chemical and building materials company, has a revised analyst price target indicating a 46.27% potential upside from its current stock price. Institutional investors like Bank of America and others are increasing their holdings, r...

Market News
Bullish
2 hours ago
PayPal stock rises on Meta AI shopping partnership and Deutsche Bank price target hike

PayPal stock rises on Meta AI shopping partnership and Deutsche Bank price target hike

PayPal's stock rose following its announcement of a new strategic partnership with Meta Platforms, integrating AI-powered shopping across its merchant network. Deutsche Bank increased its price target for PayPal to $55 from $50, signaling potential u...

Analyst Insights
Bullish
3 hours ago
Golden Spike Resources to rename as Gordon Mining Group and consolidate shares 5-for-1 on Sept 30, 2026

Golden Spike Resources to rename as Gordon Mining Group and consolidate shares 5-for-1 on Sept 30, 2026

Golden Spike Resources Corp. announced it will change its name to Gordon Mining Group Inc. and consolidate its shares on a 5-for-1 basis, reducing the total shares from about 60.6 million to approximately 12.1 million. The share consolidation and nam...

Company Fundamentals
Bullish
4 hours ago
Bitcoin holds near $84K amid macroeconomic pressures and volatile trading.

Bitcoin holds near $84K amid macroeconomic pressures and volatile trading.

Bitcoin traded mostly between $84,000 and $85,000 after reaching a weekly high above $87,000, experiencing significant intraday volatility that triggered $67 million in liquidations. Rising U.S. bond yields, oil prices above $100, and hawkish Federal...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App